3394 studies found for:    Japan
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)
Condition: Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
Interventions: Biological: Nivolumab;   Drug: Everolimus
2 Completed
Has Results
A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/GW642444 Inhalation Powder;   Drug: Fluticasone Furoate Inhalation Powder
3 Active, not recruiting
Has Results
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Condition: Hepatitis B, Chronic
Interventions: Drug: GSK548470 300 mg tablet;   Drug: ETV 0.5 mg capsule
4 Completed
Has Results
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Flutter
Interventions: Drug: warfarin;   Drug: apixaban
5 Active, not recruiting A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer (MARIANNE)
Condition: Breast Cancer
Interventions: Drug: docetaxel;   Drug: paclitaxel;   Drug: pertuzumab;   Drug: pertuzumab-placebo;   Drug: trastuzumab [Herceptin];   Drug: trastuzumab emtansine
6 Recruiting Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immuno Compromised Children With Synagis
Condition: Respiratory Syncytial Virus Infection
7 Completed A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan
Condition: Periodontitis
Intervention: Drug: Trafermin (genetical recombination)
8 Recruiting Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
Condition: Behcet's Disease
9 Completed
Has Results
Continuous Treatment Study of Topiramate in Migraine Participants
Condition: Migraine
Intervention: Drug: Topiramate
10 Active, not recruiting A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain
Condition: Endometriosis
Interventions: Drug: ASP1707;   Drug: Placebo;   Drug: Leuprorelin acetate
11 Completed
Has Results
Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: exemestane;   Drug: anastrozole
12 Completed Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial
Condition: Hepatitis C
Interventions: Drug: BI 201335 high dose;   Drug: BI201335 low dose
13 Terminated
Has Results
Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib;   Drug: Placebo
14 Completed
Has Results
Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension
Condition: Hypertension
Intervention: Drug: Micamlo
15 Recruiting A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Placebo;   Drug: CP690,550;   Drug: CP-690,550
16 Recruiting Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone Furoate/Vilanterol;   Drug: Vilanterol
17 Completed Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium + olodaterol;   Drug: tiotropium;   Drug: olodaterol
18 Completed Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response
Conditions: Philadelphia Chromosome Positive;   Chronic Myelogenous Leukemia in Chronic Phase
Intervention: Drug: Nilotinib
19 Recruiting Special Investigation in Rheumatoid Arthritis Patient Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents
Condition: Rheumatoid Arthritis
20 Completed A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: YM150;   Drug: Warfarin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years